BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15421)

  • 1. A neurobiological role for a protein activator of cyclic nucleotide phosphodiesterase.
    Uzunov P; Gnegy M; Lehne R; Revuelta A; Costa E
    Adv Biochem Psychopharmacol; 1976; 15():283-301. PubMed ID: 15421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of transsynaptically elicited increase of 3':5'-cyclic AMP by endogenous phosphodiesterase activator.
    Gnegy ME; Costa E; Uzunov P
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):352-5. PubMed ID: 174103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH
    Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of phosphodiesterase in regulation of calcium current in isolated cardiac myocytes.
    Simmons MA; Hartzell HC
    Mol Pharmacol; 1988 Jun; 33(6):664-71. PubMed ID: 2454387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
    de Vente J; Markerink-van Ittersum M; Vles JS
    J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells.
    Whalin ME; Scammell JG; Strada SJ; Thompson WJ
    Mol Pharmacol; 1991 Jun; 39(6):711-7. PubMed ID: 1646946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-regulation of intracellular cGMP and cAMP in cultured human corpus cavernosum smooth muscle cells.
    Kim NN; Huang Y; Moreland RB; Kwak SS; Goldstein I; Traish A
    Mol Cell Biol Res Commun; 2000 Jul; 4(1):10-4. PubMed ID: 11152621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [cGMP-activated phosphodiesterase from human brain: kinetic and regulatory properties].
    Bobruskin ID; Medvedeva MV; Severin ES
    Biokhimiia; 1991 Jun; 56(6):999-1010. PubMed ID: 1657216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical regulation and physiological significance of cyclic nucleotides in the nervous system.
    Kebabian JW
    Adv Cyclic Nucleotide Res; 1977; 8():421-508. PubMed ID: 21551
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential activation and inhibition of the multiple forms of cyclic nucleotide phosphodiesterase.
    Weiss B
    Adv Cyclic Nucleotide Res; 1975; 5():195-211. PubMed ID: 165666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence on adipocyte plasma membrane bound protein kinase by feedback regulator.
    Ho R; Russell T; Asakawa T; Snyder RP
    J Cyclic Nucleotide Res; 1975; 1(5):349-58. PubMed ID: 178696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME; Garrett RL; Thompson WJ; Strada SJ
    Second Messengers Phosphoproteins; 1988-1989; 12(5-6):311-25. PubMed ID: 2856115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of cyclic GMP in visnal process-activation of cyclic GMP phosphodiesterase by light and ATP (author's transl)].
    Miki N
    Tanpakushitsu Kakusan Koso; 1976 Aug; 21(8):605-11. PubMed ID: 9667
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ; Drummond GI
    J Cyclic Nucleotide Res; 1975; 1(4):219-28. PubMed ID: 177462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic 3':5'-nucleotide phosphodiesterase. Ca2+ confers more helical conformation to the protein activator.
    Liu YP; Cheung WY
    J Biol Chem; 1976 Jul; 251(14):4193-8. PubMed ID: 180019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of lens cyclic nucleotide metabolism by Ca2+ plus calmodulin.
    Louis CF; Mickelson JR; Turnquist J; Hur KC; Johnson R
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):806-14. PubMed ID: 3032838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
    Cheng J; Grande JP
    Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic nucleotide derivatives as probes of phosphodiesterase catalytic and regulatory sites.
    Erneux C; Couchie D; Dumont JE; Jastorff B
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 16():107-18. PubMed ID: 6326517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic GMP.
    Goldberg ND; O'Dea RF; Haddox MK
    Adv Cyclic Nucleotide Res; 1973; 3():155-223. PubMed ID: 4150323
    [No Abstract]   [Full Text] [Related]  

  • 20. Ca-2+/Mg-2+-dependent cyclic nucleotide phosphodiesterase and its activator protein.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
    Adv Cyclic Nucleotide Res; 1975; 5():163-78. PubMed ID: 165664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.